Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payal B Watchmaker

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Science (New York, N.Y.)|December 5, 2024
Programming tissue-sensing T cells that deliver therapies to the brainMilos S Simic, Payal B Watchmaker, Sasha Gupta, et al.
Nature Communications|May 22, 2025
Glioma-neuronal circuit remodeling induces regional immunosuppressionTakahide Nejo, Saritha Krishna, Akane Yamamichi, et al.
Science Translational Medicine|April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastomaJoseph H Choe, Payal B Watchmaker, Milos S Simic, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Journal of Clinical Investigation|June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Scientific Reports|March 17, 2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.
Nature|February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigensDarwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.
Neuro-Oncology|December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think TankPavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Science (New York, N.Y.)|December 5, 2024
Programming tissue-sensing T cells that deliver therapies to the brainMilos S Simic, Payal B Watchmaker, Sasha Gupta, et al.
Nature Communications|May 22, 2025
Glioma-neuronal circuit remodeling induces regional immunosuppressionTakahide Nejo, Saritha Krishna, Akane Yamamichi, et al.
Science Translational Medicine|April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastomaJoseph H Choe, Payal B Watchmaker, Milos S Simic, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Journal of Clinical Investigation|June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Scientific Reports|March 17, 2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.
Nature|February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigensDarwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.
Neuro-Oncology|December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think TankPavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Pageof 2